We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNT
1751
DELISTED
UNIT Corporation
UNT
-11,933
Closed -$40K
I
1752
DELISTED
INTELSAT S. A.
I
-10,486
Closed -$239K
AVX
1753
DELISTED
AVX Corporation
AVX
-4,803
Closed -$73K
DERM
1754
DELISTED
Dermira, Inc.
DERM
-19,308
Closed -$123K
LPT
1755
DELISTED
Liberty Property Trust
LPT
-222,464
Closed -$11.4M
BOLD
1756
DELISTED
Audentes Therapeutics, Inc
BOLD
-3,326
Closed -$94K
GWR
1757
DELISTED
Genesee & Wyoming Inc.
GWR
-1,087
Closed -$120K
PSDO
1758
DELISTED
Presidio, Inc. Common Stock
PSDO
-51,203
Closed -$865K
VSI
1759
DELISTED
Vitamin Shoppe Inc.
VSI
-2,784
Closed -$18K
NVTR
1760
DELISTED
Nuvectra Corporation Common Stock
NVTR
-33,469
Closed -$46K
ALDR
1761
DELISTED
Alder Biopharmaceuticals
ALDR
-125,114
Closed -$2.36M
EMMA
1762
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
-6,008
Closed -$14K
TCF
1763
DELISTED
TCF Financial Corporation Common Stock
TCF
-4,972
Closed -$189K
ELGX
1764
DELISTED
Endologix Inc
ELGX
-14,334
Closed -$57K
CBPO
1765
DELISTED
China Biologic Products Holdings, Inc.
CBPO
-25,304
Closed -$2.9M
TEUM
1766
DELISTED
Pareteum Corporation
TEUM
-189,393
Closed -$244K
PACD
1767
DELISTED
Pacific Drilling S.A. Common Shares
PACD
-7,667
Closed -$30K
NLSN
1768
DELISTED
Nielsen Holdings plc
NLSN
-138,765
Closed -$2.95M
TACO
1769
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
-293,050
Closed -$3M
MOBL
1770
DELISTED
MobileIron, Inc.
MOBL
-166,900
Closed -$1.09M
SIVB
1771
DELISTED
SVB Financial Group
SIVB
-4,356
Closed -$910K
CEMI
1772
DELISTED
Chembio diagnostics, Inc.
CEMI
-3,224
Closed -$20K
SBNY
1773
DELISTED
Signature Bank
SBNY
-20,859
Closed -$2.49M
WLL
1774
DELISTED
Whiting Petroleum Corporation
WLL
-99
Closed -$60K
WLH
1775
DELISTED
WILLIAM LYON HOMES
WLH
-110,964
Closed -$2.26M

Similar funds

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.